Dow Down1.10% Nasdaq Down1.82%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
4.60 Down 0.47(9.27%) Feb 8, 4:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.6
Mean Recommendation (last week):2.6
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:7.88
Median Target:7.50
High Target:11.00
Low Target:4.50
No. of Brokers:8

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jan 19, 2016BarclaysInitiated Underweight
Feb 26, 2014Maxim GroupUpgradeHoldBuy
Feb 26, 2014Chardan Capital MarketsDowngradeBuyNeutral
Jan 24, 2014BMO Capital MarketsUpgradeMarket PerformOutperform
Dec 23, 2013Chardan Capital MarketsUpgradeNeutralBuy
Dec 10, 2013StifelUpgradeHoldBuy
Oct 21, 2013RBC Capital MktsDowngradeOutperformSector Perform
Oct 14, 2013ArgusDowngradeHoldSell
Oct 10, 2013BarclaysDowngradeOverweightUnderweight
Oct 10, 2013Summer Street ResearchDowngradeBuyNeutral

More Upgrades & Downgrades for ARIA

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy2222
Buy1111
Hold5555
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.